Tag Archives: AdvaMed

5 Things You Didn’t Know About Off-Label Sales Compliance

Originally published in PharmaPhorum


Off-label sales compliance is difficult. There is subtlety to staying on message. Pharma sales representatives are highly mobile and verbal. Compliance and regulatory departments love paper to convey messages because they can match them up to corresponding policies. This makes the marriage of the two functions challenging. Continue reading

Perception vs. Reality of Industry Support


Last month we were discussing the changes to educational programs, something those of us in sales have long seen as a “safe harbor.” To learn the latest, review the recent White Paper (PDF) issued by the American Board of Medical Specialties which includes their discussion on commercial funding of medical education.  Thanks to our friends at Policy & Medicine for bringing this to my attention.

This is a discussion of CME programs, their future and where the line in the industry-physician support needs to be drawn. Please take a moment to review the document, and provide feedback to the ABMS committee before March 1. Continue reading

AdvaMed 2010 Highlights: Changing 510(k)s, Pricing and Healthcare Reform

Originally viewed on BeakerBeat.

To keep up with the best in Good Promotional Practices, subscribe to our GPP RSS feed, our Facebook page, our Twitter stream or our LinkedIn group.